Pharmacokinetics of Picroside Ⅱ in Rats

YU Qiao-Ling,CHEN Xi-Jing,REN Wei-Chao,ZHAO Ying,HE Hui,GAO Zi-Dong
IF: 3.887
2008-01-01
Chinese Journal of Natural Medicines
Abstract:AIM: To study the pharmacokinetics of picroside Ⅱ in rats. METHODS: Following iv. administration to rats, HPLC-MS was used to determine picroside Ⅱ concentration in plasma, tissues, feces, urine and bile. A Hypersil ODS2 column (5 μm, 150 mm ×4.6 mm I.D.) was used with a mobile phase consisting of methanol-water (47:53, v/v). The pro-tonized canions [M+Na]+ at m/z 535.00 of picroside Ⅱ , and [M+H]+at m/z 247.90 of tinidazole (IS) were analyzed by LC-ESI-MS in selected ion monitoring (SIM) mode. RESULTS: The linear range of picroside Ⅱ in plasma was 0.05~20.0 μg·mL-1 and the limit of quantitation of picroside Ⅱwas 0.05 μg·mL-1 with a recovery of more than 76%. After iv. admini-stration of 2.5, 5.0 and 10.0 mg·kg-1, the concentration of picroside Ⅱ in rats declined rapidly with mean elimination half-life time (t1/2β) of about 19.6 min. The relationship between dose and AUC showed linearity, suggesting that there was linear disposition of picrosideⅡ in rats in the dose range. Following iv. administration to rats, picroside Ⅱ was mainly dis-tributed in kidney and liver. Picroside Ⅱwas mainly excreted through bile and urine. 11.79% and 7.80% of the given dose were separately excreted in urine and bile. No picroside Ⅱ was detected in the feces. Moreover, the mean plasma protein bounding ratio of picroside Ⅱ was 30.0%. CONCLUSION: Picroside Ⅱ can be rapidly eliminated from the rat plasma, ex-tensively distributed and 19.59% of the given dose is mainly excreted in the bile and urine in parent form after iv. administra-tion.
What problem does this paper attempt to address?